Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C5H6N2O2 |
| Molecular Weight | 126.1133 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=CC(=O)NC(=O)N1
InChI
InChIKey=SHVCSCWHWMSGTE-UHFFFAOYSA-N
InChI=1S/C5H6N2O2/c1-3-2-4(8)7-5(9)6-3/h2H,1H3,(H2,6,7,8,9)
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| 1,3-Bis(4-meth-oxy-benz-yl)-6-methyl-pyrimidine-2,4(1H,3H)-dione. | 2010-06-30 |
|
| An evaluation of the chick cardiomyocyte micromass system for identification of teratogens in a blind trial. | 2009-12 |
|
| Mechanisms of cardiac muscle insensitivity to a novel acetylcholinesterase inhibitor C-547. | 2009-02 |
|
| Different sensitivity of miniature endplate currents in rat external and internal intercostal muscles to the acetylcholinesterase inhibitor C-547 as compared with diaphragm and extensor digitorum longus. | 2009 |
|
| Compounds with the dioxopyrimidine cycle inhibit cholinesterases from different groups of animals. | 2008-09-25 |
|
| Tetrakis- and tris(1-Methyluracil) complexes of Pt(II): formation and properties of a carbon-bonded nucleobase species as well as of heternonuclear derivatives. | 2007-12-24 |
|
| [Studying the nootropic effects of betamecil]. | 2007-12-15 |
|
| The design and synthesis of N-1-alkylated-5-aminoarylalkylsubstituted-6-methyluracils as potential non-nucleoside HIV-1 RT inhibitors. | 2007-12-01 |
|
| Effect of a tetraalkylammonium derivative of 6-methyluracil from a new class of acetylcholinesterase inhibitors on the endplate potential amplitude in muscles of different function types under high-frequency nerve stimulation. | 2007-10-13 |
|
| Selective oxidation of key functional groups in cyanotoxins during drinking water ozonation. | 2007-06-15 |
|
| [Realization of optic activatory mechanism in laser-medication impact]. | 2006-06-07 |
|
| Different sensitivity of miniature endplate currents of the rat extensor digitorum longus, soleus and diaphragm muscles to a novel acetylcholinesterase inhibitor C-547. | 2006 |
|
| Reaction of substituted pyrimidines with photochemically generated t-BuO* radicals. | 2005-12 |
|
| Effect of tetraalkylammonium derivatives of 6-methyluracil on the endplate potentials of muscles of different functional types. | 2005-02-19 |
|
| Electron impact mass spectral study of 1,2-di-o-(m- and p-)nitro-(bromo-)benzyl-2-thio-6-methyluracils and 1,2-di-o-(m- and p-)nitro-(bromo-)benzyl-2-thio-5-bromo-6-methyluracils. | 2005 |
|
| Biological activity of bacterial lectins and their molecular complexes with heterocyclic bis-adducts. | 2004-01-16 |
|
| Antiparasitic activity of highly conjugated pyrimidine-2,4-dione derivatives. | 2003-12 |
|
| Pyrrolidino-DNA. | 2003-10-21 |
|
| [Surgical infected wound treatment in patients with severe gastrointestinal ulcer hemorrhage]. | 2003-01-29 |
|
| [Current methods for local drug therapy of infected wounds]. | 2003 |
|
| [Photophoresis of methyluracil ointment in the complex treatment of temporomandibular pain syndrome]. | 2002-09-12 |
|
| The acidity of uracil and uracil analogs in the gas phase: four surprisingly acidic sites and biological implications. | 2002-08 |
|
| Genotoxicity study of a new tetraalkylammonium derivative of 6-methyluracil (agent No. 547). | 2002-03 |
|
| [Morphological aspects of dermatotrophic action of methyluracil applied epicutaneously]. | 2002 |
|
| [Studies of biological activity of mineral oil dialkyl disulfide (an experimental study)]. | 2002 |
|
| Tetraalkylammonium derivatives of 6-methyluracil, a new class of cholinesterase inhibitors: characteristics of interaction with cholinesterases from different groups of animals. | 2001-11-20 |
|
| Effect of tetraalkylammonium derivative of 6-methyluracil on amplitude and temporal parameters of miniature endplate potentials in frog neuromuscular junction. | 2001-05 |
|
| Structure-activity relationship of ligands of uracil phosphoribosyltransferase from Toxoplasma gondii. | 1994-08-17 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
12283
Created by
admin on Mon Mar 31 18:44:35 GMT 2025 , Edited by admin on Mon Mar 31 18:44:35 GMT 2025
|
PRIMARY | |||
|
210-949-4
Created by
admin on Mon Mar 31 18:44:35 GMT 2025 , Edited by admin on Mon Mar 31 18:44:35 GMT 2025
|
PRIMARY | |||
|
5O052W0G6I
Created by
admin on Mon Mar 31 18:44:35 GMT 2025 , Edited by admin on Mon Mar 31 18:44:35 GMT 2025
|
PRIMARY | |||
|
m7479
Created by
admin on Mon Mar 31 18:44:35 GMT 2025 , Edited by admin on Mon Mar 31 18:44:35 GMT 2025
|
PRIMARY | Merck Index | ||
|
SUB71917
Created by
admin on Mon Mar 31 18:44:35 GMT 2025 , Edited by admin on Mon Mar 31 18:44:35 GMT 2025
|
PRIMARY | |||
|
100000089069
Created by
admin on Mon Mar 31 18:44:35 GMT 2025 , Edited by admin on Mon Mar 31 18:44:35 GMT 2025
|
PRIMARY | |||
|
9456
Created by
admin on Mon Mar 31 18:44:35 GMT 2025 , Edited by admin on Mon Mar 31 18:44:35 GMT 2025
|
PRIMARY | |||
|
626-48-2
Created by
admin on Mon Mar 31 18:44:35 GMT 2025 , Edited by admin on Mon Mar 31 18:44:35 GMT 2025
|
PRIMARY | |||
|
SUB22952
Created by
admin on Mon Mar 31 18:44:35 GMT 2025 , Edited by admin on Mon Mar 31 18:44:35 GMT 2025
|
PRIMARY | |||
|
5508
Created by
admin on Mon Mar 31 18:44:35 GMT 2025 , Edited by admin on Mon Mar 31 18:44:35 GMT 2025
|
PRIMARY | |||
|
DTXSID8052308
Created by
admin on Mon Mar 31 18:44:35 GMT 2025 , Edited by admin on Mon Mar 31 18:44:35 GMT 2025
|
PRIMARY | |||
|
C008378
Created by
admin on Mon Mar 31 18:44:35 GMT 2025 , Edited by admin on Mon Mar 31 18:44:35 GMT 2025
|
PRIMARY |
SUBSTANCE RECORD
